| Term 
 | Definition 
 
        | a true solution, can be given IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | insulin that does not require a Rx |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta blockers can mask the sympotoms of this |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | this type of insulin is given between meals |  | 
        |  | 
        
        | Term 
 
        | Insulin lispro or Insulin aspart |  | Definition 
 
        | This insulin is given immediately before meals, making timing less critical |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | this insluin is given immediately before or after meals |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | this insuline is subcue at bedtime |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | This insulin is a cloudy suspension, so cannot be given IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | this insulin was recently approved for IV use in clinical settings ONLY |  | 
        |  | 
        
        | Term 
 
        | Insulin glargine or insuline detemir |  | Definition 
 
        | this insulin cannot be used in the same syringe as other insulins or rapid analogs bc of the zinc and low pH affecting other drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | this insulin has some early evidence of slightly increased cancer |  | 
        |  | 
        
        | Term 
 
        | Insulin glargine or insulin detemir(less variable) |  | Definition 
 
        | this insulin gives long, low, constant action by precipitating in tissues and then slowly and variably being absorbed |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | an IM or subcue agent used to treat hypoglycemia, especially in unconscious patients |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | This hypoglycemic agent inhibits release of insulin by opening ATP-sensitive K+ channels to block insulin secretion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | This hypoglycemic agent is given orally |  | 
        |  | 
        
        | Term 
 
        | Detemir/glargine>isophane>regular>lispro/aspart/glulisine |  | Definition 
 
        | The pharmakokinetics of insulin preparations from long to rapid |  | 
        |  |